APA (7th ed.) Citation

Izumi, A., Tachibana, T., Ando, T., Tanaka, M., Kanamori, H., & Nakajima, H. (2022). A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation. International journal of hematology, 115(1), 69-76. https://doi.org/10.1007/s12185-021-03217-4

Chicago Style (17th ed.) Citation

Izumi, Akihiko, Takayoshi Tachibana, Taiki Ando, Masatsugu Tanaka, Heiwa Kanamori, and Hideaki Nakajima. "A Case Series of Patients Treated with Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia Relapsed After Allogeneic Hematopoietic Cell Transplantation." International Journal of Hematology 115, no. 1 (2022): 69-76. https://doi.org/10.1007/s12185-021-03217-4.

MLA (9th ed.) Citation

Izumi, Akihiko, et al. "A Case Series of Patients Treated with Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia Relapsed After Allogeneic Hematopoietic Cell Transplantation." International Journal of Hematology, vol. 115, no. 1, 2022, pp. 69-76, https://doi.org/10.1007/s12185-021-03217-4.